Loxenatide
Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia
Company n/r · Phase 2/3 · Completed · Enrollment 30
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| LNG-IUS | n/r | n/r | n/r | n/r | n/r |
| LOX+LNG-IUS | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.